Teeple A, Muser E. Cost Per Responder Analysis of Guselkumab versus Adalimumab using Efficacy Results fromm a Head-to-Head Clinical Trial in Patients with Moderate to Severe Plaque Psoriasis. J of Skin [Internet]. 2017 Oct. 27 [cited 2024 Jul. 23];1(3.1):s6. Available from: https://jofskin.org/33014/index.php/skin/article/view/157